Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 6, 2024Statistics in MedicineOpen Access

A seamless phase II/III design with dose optimization for oncology drug development

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYuhan LiYZYiding ZhangGMGu Mi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e65d24b6db6435875ec034https://doi.org/10.1002/sim.10129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Flexible seamless 2-in-1 design with sample size adaptation2024 · 9 citations
  2. 2Estimation of clinical trial success rates and related parameters2017 · 1,594 citations
  3. 3An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†2010 · 214 citations
  4. 4Sample Size Re-estimation Designs In Confirmatory Clinical Trials—Current State, Statistical Considerations, and Practical Guidance2015 · 39 citations